@jepcastel

Immortal time bias in estimates of mortality among infliximab-treated patients with Crohn's disease.

. Gut, 59 (11): 1586-7 (November 2010)5816<m:linebreak></m:linebreak>JID: 2985108R; 0 (Antibodies, Monoclonal); 0 (Gastrointestinal Agents); 0 (infliximab); CON: Gut. 2009 Apr;58(4):501-8. PMID: 18832524; 2010/08/23 aheadofprint; ppublish;.
DOI: 10.1136/gut.2009.191015

Links and resources

Tags